Sunday, 11 April 2021


Perrigo rejects Mylan's acquisition bid

28 April 2015 | News | By BioSpectrum Bureau

Perrigo rejects Mylan's acquisition bid

Mylan has reproposed a price that is lower than the previously rejected proposal

Mylan has reproposed a price that is lower than the previously rejected proposal

Singapore: Irish firm, Perrigo, has declined the acquisition offer from Mylan revalued at USD60 per share in cash and 2.2 Mylan ordinary shares for each ordinary Perrigo share.

The Board previously concluded that Mylan's unsolicited proposal of USD205.00 per share significantly undervalued the company and its future growth prospects and was not in the best interests of Perrigo's shareholders.

Mylan has reproposed a price that is lower than the previously rejected proposal. Perrigo has advised its shareholders to take no action in relation to the Offer.

Sign up for the editor pick and get articles like this delivered right to your inbox.

Editors Pick
+Country Code-Phone Number(xxx-xxxxxxx)


Comments

× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account